Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mu... Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of?Validive?for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin?for the treatment?of advanced soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers. Show more
WILMETTE, Ill., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients...
WILMETTE, Ill., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients...
WILMETTE, Ill., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer...
WILMETTE, Ill., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.94 | 20.6593406593 | 4.55 | 5.66 | 4.52 | 71713 | 5.06595121 | CS |
4 | 1.54 | 38.9873417722 | 3.95 | 7.18 | 3.33 | 408766 | 5.33861224 | CS |
12 | 1.84 | 50.4109589041 | 3.65 | 7.18 | 1.719 | 912931 | 4.04527498 | CS |
26 | 1.725 | 45.8167330677 | 3.765 | 7.18 | 1.719 | 493182 | 4.01769465 | CS |
52 | 2.99 | 119.6 | 2.5 | 8.65 | 1.3695 | 1868454 | 4.55300626 | CS |
156 | -17.61 | -76.2337662338 | 23.1 | 28.7 | 1.3695 | 675587 | 4.73123769 | CS |
260 | -115.21 | -95.4515327258 | 120.7 | 240 | 1.3695 | 454586 | 7.70372198 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.